Clinuvel Pharmaceuticals reports 2H results
Source: SeekingAlpha
2026-02-26 12:08:35 ET
More on Clinuvel Pharmaceuticals
- Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Clinuvel Pharmaceuticals
- Historical earnings data for Clinuvel Pharmaceuticals
- Dividend scorecard for Clinuvel Pharmaceuticals
- Financial information for Clinuvel Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Clinuvel Pharmaceuticals reports 2H results
Clinuvel Pharms Ltd S/Adr
NASDAQ: CLVLY
CLVLY Trading
1.5% G/L:
$7.46 Last:
354 Volume:
$7.35 Open:
CLVLY Latest News
September 28, 2025 10:56:51 pm
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
March 03, 2025 09:17:55 pm
Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025
CLVLY Stock Data
$408,995,919
44,689,186
N/A
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne
